Auxilium Pharmaceuticals News

MALVERN, Pa., and WILMINGTON, Del., May 24, 2012 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc.

But the numbers for companies making the product for men are clear and direct, which is why Auxilium Pharmaceuticals Inc., of Malvern, Pa., and GlaxoSmithKline announced a deal Monday to try to sell more of Testim, Auxilium's prescription form of the gel.

Podcast host, "Have the Life You Want with Ken Howard, LCSW", 36 episodes On-camera talent, E! Entertainment Television, "Fifty Wickedest Women of Prime Time" On-camera talent, Carl's Jr.

MALVERN, Pa., May 21, 2012 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. is raising its full year 2012 revenue guidance to a range of $293 to $315 million and is reducing its guidance for net loss to a range of $5 to $10 million.

Auxilium Pharmaceuticals, Inc. and GlaxoSmithKline entered into an agreement Monday to co-promote Testim, Auxilium's testosterone replacement therapy product used in adult males.

Austin-based Respira Therapeutics Inc. has added Armando Anido , the former president and chief executive of Auxilium Pharmaceuticals Inc., to its board of directors.

The 10-second takeaway For the quarter ended March 31 , Auxilium Pharmaceuticals beat expectations on revenues and exceeded expectations on earnings per share.

Molycorp, Inc : JPMorgan lowered its estimates and price target for Molycorp and says it remains cautious on the stock as the outlook for rare earth prices continues to fall.

MALVERN, PA., May 11, 2012 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. today announced that executive management will participate in the BofAML 2012 Health Care Conference to be held May 15-17, 2012 at the Encore at the Wynn in Las Vegas.

Other equities research analysts have also recently issued reports about the stock.

MALVERN, Pa., May 9, 2012 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. , a specialty biopharmaceutical company, today announced that The Journal of Urology has published on its website, the Company's phase IIb clinical trial of XIAFLEX a novel, first-in-class, biologic for the potential nonsurgical treatment of Peyronie's disease.

MALVERN, Pa., May 3, 2012 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. , a specialty biopharmaceutical company, will release results for the first quarter 2012 on Thursday, May 10, 2012 before the opening of the U.S. financial markets.